Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum IGF1 and linear growth in children with congenital leptin deficiency before and after leptin substitution. | Int J Obes (Lond) | 2021 | 34002033 | PubTator, text mining | PubMed |
| Increased EHHADH Expression Predicting Poor Survival of Osteosarcoma by Integrating Weighted Gene Coexpression Network Analysis and Experimental Validation. | Biomed Res Int | 2021 | 33997049 | PubTator, text mining | PubMed |
| Identification of Hub Genes and Their Correlation With Immune Infiltration Cells in Hepatocellular Carcinoma Based on GEO and TCGA Databases. | Front Genet | 2021 | 33995482 | PubTator, text mining | PubMed |
| Clonal Upregulation of Effector Cytotoxic T Lymphocytes in a Patient with Multiple Tyrosine Kinase Inhibitor-Refractory Chronic Myeloid Leukemia with Long-Term Survival. | Case Rep Oncol | 2021 | 33976626 | PubTator, text mining | PubMed |
| Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients. | Sci Rep | 2021 | 33972591 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| The Struggling Odyssey of Infantile Primary Hyperoxaluria. | Front Pediatr | 2021 | 33959570 | PubTator, text mining | PubMed |
| Discovery of Novel, Potent Inhibitors of Hydroxy Acid Oxidase 1 (HAO1) Using DNA-Encoded Chemical Library Screening. | J Med Chem | 2021 | 33955740 | PubTator, text mining | PubMed |
| CRISPR/Cas9 deletion of ORMDLs reveals complexity in sphingolipid metabolism. | J Lipid Res | 2021 | 33939982 | PubTator, text mining | PubMed |
| Nanoparticles as Drug Delivery Systems of RNAi in Cancer Therapy. | Molecules | 2021 | 33921892 | PubTator, text mining | PubMed |
| Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy. | Cancers (Basel) | 2021 | 33920887 | PubTator, text mining | PubMed |
| Dimerization Drives Proper Folding of Human Alanine:Glyoxylate Aminotransferase But Is Dispensable for Peroxisomal Targeting. | J Pers Med | 2021 | 33917320 | PubTator, text mining | PubMed |
| Molecular Mechanism of Cannabinoids in Cancer Progression. | Int J Mol Sci | 2021 | 33916164 | PubTator, text mining | PubMed |
| Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria. | Kidney Int Rep | 2021 | 33912759 | PubTator, text mining | PubMed |
| [Interferent RNA treatment: Example of primary hyperoxaluria]. | Nephrol Ther | 2021 | 33910694 | PubTator, text mining | PubMed |
| Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis. | Front Med (Lausanne) | 2021 | 33898474 | PubTator, text mining | PubMed |
| Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey method. | BMC Genomics | 2021 | 33879046 | PubTator, text mining | PubMed |
| The Relationship of the Type of Intracerebral Hemorrhage to Early Disease Evolution and Long-Term Prognosis After r-tPA Thrombolysis. | Clin Appl Thromb Hemost | 2021 | 33872083 | PubTator, text mining | PubMed |
| MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660. | Mol Ther Nucleic Acids | 2021 | 33868783 | PubTator, text mining | PubMed |
| German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis. | BMC Neurol | 2021 | 33865337 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=52